Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
D018929:Cell Culture Techniques; D002999:Clone Cells / Q000166:cytology / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D005260:Female; D020544:Graft vs Leukemia Effect; D006684:HLA-DR Antigens / Q000032:analysis; D006410:Hematopoiesis; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000628:therapy*; D017710:Lymphocyte Transfusion / Q000379:methods*; D008297:Male; D015778:Minor Histocompatibility Antigens / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy; D009363:Neoplasm Proteins / Q000276:immunology; D009842:Oligopeptides / Q000276:immunology; D016879:Salvage Therapy / Q000379:methods; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology* / Q000637:transplantation; D013602:T-Lymphocytes, Cytotoxic / Q000166:cytology / Q000276:immunology; D014184:Transplantation, Homologous
C110615:HA-1 antigen; C080145:HA-2 antigen; D006684:HLA-DR Antigens; D015778:Minor Histocompatibility Antigens; D009363:Neoplasm Proteins; D009842:Oligopeptides